Heparin inhibits lipopolysaccharide-induced inflammation via inducing caveolin-1 and activating the p38/mitogen-activated protein kinase pathway in murine peritoneal macrophages

作者: ZHIYONG LIU , LIANG WANG , ZHE DONG , JIEYI PAN , HONG ZHU

DOI: 10.3892/MMR.2015.3807

关键词: Tumor necrosis factor alphap38 mitogen-activated protein kinasesMAPK/ERK pathwayProinflammatory cytokineMolecular biologyPharmacologyHeparinCaveolin 1Protein kinase ABiologyInflammation

摘要: Abstract Heparin is a soluble glycosaminoglycan largely used as an anti-coagulant drug and with well known anti‑inflammatory effects. However, heparin currently not agent in the clinic due to risk of bleeding its complex mechanism action. The underlying action effector targets have remained be fully elucidated. present study confirmed effects lipopolysaccharide (LPS)‑induced murine peritoneal macrophages through decreasing levels inflammatory cytokines tumor necrosis factor alpha (TNF‑α), interleukin 6 (IL‑6), IL‑8 IL‑1β. Caveolin‑1 participated process it was able induced by heparin. Transfection small interfering RNA caveolin‑1 into attenuated Furthermore, following silencing, p38/mitogen‑activated protein kinase (MAPK) pathway still activated heparin, while extracellular signal‑regulated c‑Jun N‑terminal pathways were inhibited. In conclusion, these results suggested that inhibits LPS‑induced inflammation via inducing activating p38/MAPK macrophages. Revealing mechanisms will aid development for clinical treatment future.

参考文章(23)
Mihaela Gadjeva, Catherine Paradis-Bleau, Gregory P. Priebe, Raina Fichorova, Gerald B. Pier, Caveolin-1 Modifies the Immunity to Pseudomonas aeruginosa Journal of Immunology. ,vol. 184, pp. 296- 302 ,(2010) , 10.4049/JIMMUNOL.0900604
Clive P. Page, Rebecca Lever, Non-anticoagulant effects of heparin: an overview. Handbook of experimental pharmacology. pp. 281- 305 ,(2012) , 10.1007/978-3-642-23056-1_12
R T Barrow, E T Parker, S Krishnaswamy, P Lollar, Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator. Journal of Biological Chemistry. ,vol. 269, pp. 26796- 26800 ,(1994) , 10.1016/S0021-9258(18)47089-5
Hong Feng, Ling Guo, Zhiqing Song, Haiqing Gao, Dan Wang, Weisi Fu, Jingyan Han, Zhenyu Li, Bin Huang, Xiang-An Li, Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis. Journal of Biological Chemistry. ,vol. 285, pp. 25154- 25160 ,(2010) , 10.1074/JBC.M110.116897
Dongmei Zhao, Renyu Ding, Yiran Mao, Liang Wang, Zhidan Zhang, Xiaochun Ma, Heparin rescues sepsis-associated acute lung injury and lethality through the suppression of inflammatory responses. Inflammation. ,vol. 35, pp. 1825- 1832 ,(2012) , 10.1007/S10753-012-9503-0
Jiangwei Li, Alexis Scherl, Freddy Medina, Philippe G. Frank, Richard N. Kitsis, Herbert B. Tanowitz, Federica Sotgia, Michael P. Lisanti, Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle. ,vol. 4, pp. 1599- 1607 ,(2005) , 10.4161/CC.4.11.2117
Catherine Hayward, Advances in understanding "high on-treatment platelet reactivity". Thrombosis and Haemostasis. ,vol. 102, pp. 799- 800 ,(2009) , 10.1160/TH09-09-0617
Timothy E. Peterson, Laurel S. Kleppe, Noel M. Caplice, Shuchong Pan, Cheryl S. Mueske, Robert D. Simari, The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells. Biochemical and Biophysical Research Communications. ,vol. 265, pp. 722- 727 ,(1999) , 10.1006/BBRC.1999.1738